| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/08/2023 | 86.05% | JP Morgan | $21 → $20 | Maintains | Overweight |
| 10/10/2023 | 95.35% | JP Morgan | → $21 | Initiates Coverage On | → Overweight |
| 10/10/2023 | 67.44% | B of A Securities | → $18 | Initiates Coverage On | → Buy |
| 10/10/2023 | — | William Blair | Initiates Coverage On | → Outperform | |
| 10/10/2023 | 104.65% | Guggenheim | → $22 | Initiates Coverage On | → Buy |
| 10/10/2023 | 123.26% | RBC Capital | → $24 | Initiates Coverage On | → Outperform |
| 10/10/2023 | 141.86% | Stifel | → $26 | Initiates Coverage On | → Buy |
What is the target price for Neumora Therapeutics (NMRA)?
The latest price target for Neumora Therapeutics (NASDAQ: NMRA) was reported by JP Morgan on November 8, 2023. The analyst firm set a price target for $20.00 expecting NMRA to rise to within 12 months (a possible 86.05% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Neumora Therapeutics (NMRA)?
The latest analyst rating for Neumora Therapeutics (NASDAQ: NMRA) was provided by JP Morgan, and Neumora Therapeutics maintained their overweight rating.
When is the next analyst rating going to be posted or updated for Neumora Therapeutics (NMRA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Neumora Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Neumora Therapeutics was filed on November 8, 2023 so you should expect the next rating to be made available sometime around November 8, 2024.
Is the Analyst Rating Neumora Therapeutics (NMRA) correct?
While ratings are subjective and will change, the latest Neumora Therapeutics (NMRA) rating was a maintained with a price target of $21.00 to $20.00. The current price Neumora Therapeutics (NMRA) is trading at is $10.75, which is out of the analyst's predicted range.